Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) reached a new 52-week low during trading on Thursday after Royal Bank Of Canada lowered their price target on the stock from $28.00 to $22.00. Royal Bank Of Canada currently has an outperform rating on the stock. Acadia Healthcare traded as low as $16.91 and last traded at $17.2560, with a volume of 48066 shares traded. The stock had previously closed at $17.41.
Several other research firms have also recently commented on ACHC. Guggenheim reduced their target price on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a research note on Monday. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, October 8th. Bank of America cut Acadia Healthcare from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $27.00 to $25.00 in a research note on Wednesday, September 10th. Mizuho lowered their price objective on shares of Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 13th. Finally, Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $32.82.
Read Our Latest Stock Analysis on Acadia Healthcare
Institutional Investors Weigh In On Acadia Healthcare
Acadia Healthcare Price Performance
The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The firm has a market cap of $1.57 billion, a P/E ratio of 11.26, a PEG ratio of 4.56 and a beta of 0.97. The firm has a 50-day simple moving average of $23.02 and a 200-day simple moving average of $22.71.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.71 by $0.01. The business had revenue of $851.57 million for the quarter, compared to the consensus estimate of $852.43 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business’s revenue for the quarter was up 4.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 4 High-Yield Real Estate Stocks to Buy as Investors Get Defensive
- What is the Shanghai Stock Exchange Composite Index?
- Oklo’s Meltdown Is Over: A Robust Rebound Lies Ahead
- What is the Nikkei 225 index?
- 3 Reasons On Holding’s Sell-Off Is Over and New Highs Are Coming
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
